BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10

• Press Releases

  Novonesis and Novo Nordisk will explore new solutions to improve metabolic health

  September 8, 2025

   · 

  4 min read
• Press Releases

  Grant Awarded to Investigator-Initiated Phase 2/3 Trial with Mitazalimab in Biliary Tract Cancer

  September 8, 2025

   · 

  3 min read
• Press Releases

  Hemogenyx Pharmaceuticals PLC Announces Manufacturing Partnership with Made Scientific

  September 8, 2025

   · 

  3 min read
• Press Releases

  CHARM Therapeutics Appoints Dr Erkut Bahceci as Chief Medical Officer

  September 8, 2025

   · 

  2 min read
• Press Releases

  Rapport Announces Positive Topline Results from Phase 2a Clinical Trial of RAP-219 in Patients with Focal Onset Seizures

  September 8, 2025

   · 

  13 min read
• Press Releases

  FDA Accepts Letter of Intent to Qualify LSM by VCTE (FibroScan®) as First Non-Invasive Surrogate Endpoint in MASH Clinical Trials

  September 8, 2025

   · 

  4 min read
• Press Releases

  Positive Study Results with TrkA-NAM ACD137 Against Knee Osteoarthritis Presented at Pain Conference NeuPSIG 2025

  September 8, 2025

   · 

  5 min read
• Press Releases

  Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

  September 8, 2025

   · 

  3 min read
• Press Releases

  IDEAYA Biosciences Announces Positive Interim Phase 2 Data for Darovasertib in the Neoadjuvant Setting of Primary Uveal Melanoma

  September 8, 2025

   · 

  6 min read
• Press Releases

  Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies

  September 8, 2025

   · 

  14 min read